
|Articles|February 4, 2022
Daily Medication Pearl: Tavaborole (Kerydin)
Author(s)Saro Arakelians, PharmD
Tavaborole (Kerydin) is indicated for the topical treatment of onychomycosis of the toenails.
Advertisement
Medication Pearl of the Day: Tavaborole (Kerydin)
Indication: Tavaborole (Kerydin) is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes.
Insight:
- Dosing: Apply tavaboroleto affected toenails once daily for 48 weeks.
- Dosage forms:Solution, 5%.
- Adverse events: Common adverse reactions occurring in ≥1% in subjects treated with tavaboroleincluded application site exfoliation, ingrown toenail, application site erythema, and application site dermatitis.
- Mechanism of action: Kerydin is an oxaborole antifungal.
- Manufacturer: Anacor Pharma
Sources:
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 Trial Marks First Success for Personalized mRNA Cancer Therapy in Resected Melanoma
2
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
3
Enlicitide and the New Wave of PCSK9 Inhibitors
4
Fentanyl-Responsive Microneedle Patch Automatically Releases Naloxone in Preclinical Study
5




































































































